Loading stock data...

Titan Biotech Limited

BSE: TITANBIO

BSE
445.95 -8.15 (-1.79%)

Prev Close

454.1

Open Price

454.1

Volume

4,886

Today Low / High

440.2 / 454.1

52 WK Low / High

373.65 / 800

Range

424 - 468

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 445.95, reflecting a change of -8.15 (-1.79476%). The expected target range on the BSE is 424 - 468. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

22 Aug 454.10 -1.79%
21 Aug 468.00 -2.97%
20 Aug 461.00 -0.44%
19 Aug 465.00 -1.75%
18 Aug 479.00 -3.42%
14 Aug 454.80 3.58%
13 Aug 445.00 -0.94%
12 Aug 449.90 -2.90%
11 Aug 436.30 1.23%
08 Aug 464.00 -4.67%
07 Aug 465.00 -0.22%
06 Aug 481.05 -1.82%
05 Aug 452.10 8.57%
04 Aug 423.00 7.61%
01 Aug 425.10 -0.41%
31 Jul 425.30 0.41%
30 Jul 444.00 -2.26%
29 Jul 440.00 -0.65%
28 Jul 448.95 -1.92%

Titan Biotech Limited Graph

Titan Biotech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Titan Biotech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 445.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 445.95 450.41 405.37 - 495.45
454.87 363.90 - 545.84
459.33 321.53 - 597.13
Bearish Scenario 445.95 441.49 397.34 - 485.64
437.03 349.62 - 524.44
432.57 302.80 - 562.34

Overview of Titan Biotech Limited

ISIN

INE150C01011

Industry

Biotechnology

Vol.Avg

8,085

Market Cap

3,685,197,015

Last Dividend

2

Official Website

Visit Website

IPO Date

2000-11-30

DCF Diff

85.36

DCF

361

Financial Ratios Every Investor Needs

Stock Dividend of TITANBIO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 2 2 2025-09-19 2025-10-26
2024-09-23 September 23, 24 2 2 2024-09-23 2024-10-30
2023-09-22 September 22, 23 1.8 1.8 2023-09-22 2023-10-29
2022-09-22 September 22, 22 1.5 1.5 2022-09-23 2022-10-30
2021-09-16 September 16, 21 1.5 1.5 2021-09-17 2021-10-24

Stock Rating Details for TITANBIO

Metric Value Recommendation
Overall Rating A Buy
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 156.45 Cr 72.63 Cr 83.82 Cr 0.5358 0.00 Cr 0.00 Cr 21.26 Cr 21.53 Cr 26.04 29.34 Cr 0.1376
2024-03-31 164.07 Cr 120.78 Cr 43.30 Cr 0.2639 0.13 Cr 2.39 Cr 31.59 Cr 24.85 Cr 30.07 35.80 Cr 0.1515
2023-03-31 144.00 Cr 85.64 Cr 58.36 Cr 0.4053 0.10 Cr 1.84 Cr 27.43 Cr 24.84 Cr 30.06 31.46 Cr 0.1725
2022-03-31 123.55 Cr 70.53 Cr 53.02 Cr 0.4291 0.00 Cr 1.40 Cr 29.24 Cr 21.68 Cr 26.24 32.03 Cr 0.1755
2021-03-31 142.24 Cr 75.28 Cr 66.95 Cr 0.4707 0.04 Cr 1.51 Cr 44.37 Cr 30.34 Cr 36.71 46.40 Cr 0.2133

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 5.13 Cr 174.71 Cr 21.30 Cr 153.4032 Cr 2.80 Cr -2.33 Cr 50.72 Cr 58.85 Cr 0.00 Cr 0.00 Cr 0.00 Cr 17.7364 Cr
2024-03-31 2.84 Cr 157.63 Cr 24.18 Cr 133.4512 Cr 8.30 Cr 5.46 Cr 46.61 Cr 54.47 Cr 1.96 Cr 0.00 Cr 28.55 Cr 19.1252 Cr
2023-03-31 4.86 Cr 134.52 Cr 24.60 Cr 109.9109 Cr 8.51 Cr 3.65 Cr 36.17 Cr 49.10 Cr 2.09 Cr 0.00 Cr 15.67 Cr 20.3505 Cr
2022-03-31 6.81 Cr 108.09 Cr 21.85 Cr 86.2441 Cr 8.93 Cr 2.12 Cr 34.68 Cr 38.51 Cr 1.27 Cr 0.00 Cr 0.00 Cr 16.9494 Cr
2021-03-31 5.45 Cr 100.72 Cr 28.24 Cr 68.7582 Cr 14.79 Cr 9.34 Cr 32.54 Cr 33.79 Cr 0.00 Cr 0.00 Cr 7.83 Cr 19.2796 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 20.1233 Cr -9.8747 Cr -7.9608 Cr 10.6793 Cr 2.2878 Cr 5.1279 Cr -9.3901 Cr 24.3673 Cr -5.0688 Cr -1.6527 Cr -5.1518 Cr
2024-03-31 21.1463 Cr -20.3037 Cr -2.8662 Cr 1.4567 Cr -2.0236 Cr 2.8401 Cr -19.6896 Cr 24.8530 Cr 0.1724 Cr -1.4875 Cr -9.4015 Cr
2023-03-31 21.1783 Cr -20.7252 Cr -2.4034 Cr 7.7138 Cr -1.9502 Cr 4.8637 Cr -13.1702 Cr 28.1161 Cr -0.5328 Cr -1.2396 Cr -1.4898 Cr
2022-03-31 22.0407 Cr -16.4366 Cr -4.0988 Cr 8.3604 Cr 1.5054 Cr 6.8139 Cr -18.7850 Cr 28.9690 Cr -1.7369 Cr -1.2396 Cr -9.7567 Cr
2021-03-31 19.0821 Cr -4.8649 Cr -10.5993 Cr 14.2172 Cr 3.6179 Cr 5.4506 Cr -4.8649 Cr 42.7056 Cr -9.7538 Cr -0.8264 Cr -4.5620 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 35.17 Cr 15.01 Cr 20.16 Cr 0.5731 3.73 Cr 4.05 Cr 4.89 5.95 Cr 0.1151
2024-12-31 38.28 Cr 18.34 Cr 19.94 Cr 0.5209 3.66 Cr 4.39 Cr 5.31 6.44 Cr 0.1147
2024-09-30 39.89 Cr 17.51 Cr 22.38 Cr 0.5610 6.66 Cr 6.70 Cr 8.10 8.08 Cr 0.1678
2024-06-30 43.11 Cr 29.09 Cr 14.03 Cr 0.3254 7.20 Cr 6.40 Cr 7.74 8.87 Cr 0.1484
2024-03-31 39.92 Cr 25.93 Cr 13.99 Cr 0.3504 6.24 Cr 5.00 Cr 6.05 7.56 Cr 0.1252

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 5.13 Cr 0.43 Cr 5.56 Cr 18.82 Cr 50.72 Cr 79.04 Cr 58.85 Cr 174.71 Cr 21.30 Cr
2024-12-31 0.00 Cr 0.00 Cr 10.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -144.98 Cr
2024-09-30 8.06 Cr 1.97 Cr 10.03 Cr 24.04 Cr 49.29 Cr 91.40 Cr 59.21 Cr 173.10 Cr 28.12 Cr
2024-06-30 0.00 Cr 0.00 Cr 2.84 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -133.45 Cr
2024-03-31 2.84 Cr 0.00 Cr 2.84 Cr 18.71 Cr 46.61 Cr 72.17 Cr 54.47 Cr 157.63 Cr 24.18 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 4.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 6.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 6.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 5.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 7.17 Cr 1.67 Cr 0.00 Cr 0.00 Cr 1.67 Cr 6.23 Cr 4.56 Cr 0.00 Cr 1.67 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹359.50 ₹480,637,120,000.00 ₹1,022,580.00
Syngene International Limited SYNGENE ₹667.40 ₹267,870,930,256.00 ₹196,956.00
Piramal Pharma Limited PPLPHARMA ₹192.75 ₹256,212,590,550.00 ₹2,776,948.00
Concord Biotech Limited CONCORDBIO ₹1,767.60 ₹184,919,595,120.00 ₹188,946.00
Blue Jet Healthcare Limited BLUEJET ₹775.35 ₹134,496,413,397.00 ₹242,236.00
Jubilant Ingrevia Limited JUBLINGREA ₹717.05 ₹114,212,441,050.00 ₹143,014.00
Supriya Lifescience Limited SUPRIYA ₹689.55 ₹55,496,914,740.00 ₹82,197.00
Dishman Carbogen Amcis Limited DCAL ₹268.15 ₹42,041,361,450.00 ₹62,573.00
Zota Health Care Limited ZOTA ₹1,269.70 ₹38,227,365,780.00 ₹33,784.00

Key Executives

Whole Time Director
Mr. Udit Singla

Gender: male

Year Born:

MD & Executive Director
Mr. Naresh Kumar Singla

Gender: male

Year Born: 1959

Company Secretary, Compliance & Legal Officer and HOD of HR
Mr. Charanjit Singh

Gender: male

Year Born:

MD & Executive Director
Mr. Suresh Chand Singla

Gender: male

Year Born: 1960

Senior Vice President of Production & Whole Time Director
Mr. Raja Singla

Gender: male

Year Born:

Vice President of Admn.
Ms. Madhu Gupta Singla

Gender: female

Year Born:

Chief Financial Officer
Mr. Prem Shankar Gupta

Gender: male

Year Born:

Whole Time Director
Mr. Shivom Singla

Gender: male

Year Born: 1993

FAQs about Titan Biotech Limited

Who is the CEO of the company?

The CEO is Naresh Kumar Singla.

What is the current market price of the stock?

The current price is ₹445.95.

What is the 52-week price range?

The range is ₹373.65-800.

What is the market capitalization of the company?

The market capitalization is ₹368.52 crores.

What is the dividend yield?

The dividend yield is 0.45%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.12.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Titan Biotech Limited (ISIN: INE150C01011) is a leading Biotechnology in India. With a market capitalization of ₹368.52 crores and an average daily volume of 8,085 shares, it operates in the Biotechnology. The company last declared a dividend of ₹2.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack